Literature DB >> 6876174

Structure of porcine pancreatic phospholipase A2 at 2.6 A resolution and comparison with bovine phospholipase A2.

B W Dijkstra, R Renetseder, K H Kalk, W G Hol, J Drenth.   

Abstract

The previously published three-dimensional structure of porcine pancreatic prophospholipase A2 at 3 A resolution was found to be incompatible with the structures of bovine phospholipase A2 and bovine prophospholipase A2. This was unexpected because of the very homologous amino acid sequences of these enzymes. Therefore, the crystal structure of the porcine enzyme was redetermined using molecular replacement methods with bovine phospholipase as the parent model. The structure was crystallographically refined at 2.6 A resolution by fast Fourier transform and restrained least-squares procedures to an R-factor of 0.241. The crystals appeared to contain phospholipase A2 and not prophospholipase A2. Apparently the protein is slowly converted under the crystallization conditions employed. Our investigation shows that, in contrast to the previous report, the three-dimensional structure of porcine phospholipase A2 is very similar to that of bovine phospholipase A2, including the active site. Smaller differences were observed in some residues involved in the binding of aggregated substrates. However, an appreciable conformational difference is in the loop 59 to 70, where a single substitution at position 63 (bovine Val leads to porcine Phe) causes a complete rearrangement of the peptide chain. In addition to the calcium ion in the active site, a second calcium ion is present in the crystals; this is located on a crystallographic 2-fold axis and stabilizes the interaction between two neighbouring molecules.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6876174     DOI: 10.1016/s0022-2836(83)80328-3

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  28 in total

1.  Otoconin-90, the mammalian otoconial matrix protein, contains two domains of homology to secretory phospholipase A2.

Authors:  Y Wang; P E Kowalski; I Thalmann; D M Ornitz; D L Mager; R Thalmann
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

2.  Postprandial lysophospholipid suppresses hepatic fatty acid oxidation: the molecular link between group 1B phospholipase A2 and diet-induced obesity.

Authors:  Eric D Labonté; Paul T Pfluger; James G Cash; David G Kuhel; Juan C Roja; Daniel P Magness; Ronald J Jandacek; Matthias H Tschöp; David Y Hui
Journal:  FASEB J       Date:  2010-03-09       Impact factor: 5.191

3.  Group 1B phospholipase A2-mediated lysophospholipid absorption directly contributes to postprandial hyperglycemia.

Authors:  Eric D Labonté; R Jason Kirby; Nicholas M Schildmeyer; April M Cannon; Kevin W Huggins; David Y Hui
Journal:  Diabetes       Date:  2006-04       Impact factor: 9.461

4.  Solution structure of porcine pancreatic phospholipase A2 complexed with micelles and a competitive inhibitor.

Authors:  B van den Berg; M Tessari; R Boelens; R Dijkman; R Kaptein; G H de Haas; H M Verheij
Journal:  J Biomol NMR       Date:  1995-02       Impact factor: 2.835

5.  The electrostatic basis for the interfacial binding of secretory phospholipases A2.

Authors:  D L Scott; A M Mandel; P B Sigler; B Honig
Journal:  Biophys J       Date:  1994-08       Impact factor: 4.033

6.  Studies on the status of lysine residues in phospholipase A2 from Naja naja atra (Taiwan cobra) snake venom.

Authors:  C C Yang; L S Chang
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

7.  Functional involvement of Lys-6 in the enzymatic activity of phospholipase A2 from Bungarus multicinctus (Taiwan banded krait) snake venom.

Authors:  L S Chang; K W Kuo; S R Lin; C C Chang
Journal:  J Protein Chem       Date:  1994-10

8.  Structural insight into the activation mechanism of human pancreatic prophospholipase A2.

Authors:  Wei Xu; Lina Yi; Yumei Feng; Ling Chen; Jinsong Liu
Journal:  J Biol Chem       Date:  2009-03-18       Impact factor: 5.157

9.  Chemical modification and inactivation of phospholipases A2 by a manoalide analogue.

Authors:  S Fujii; Y Tahara; M Toyomoto; S Hada; H Nishimura; S Inoue; K Ikeda; Y Inagaki; S Katsumura; Y Samejima
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

10.  Interisland mutation of a novel phospholipase A2 from Trimeresurus flavoviridis venom and evolution of Crotalinae group II phospholipases A2.

Authors:  Takahito Chijiwa; Sachiko Hamai; Shoji Tsubouchi; Tomohisa Ogawa; Masanobu Deshimaru; Naoko Oda-Ueda; Shosaku Hattori; Hiroshi Kihara; Susumu Tsunasawa; Motonori Ohno
Journal:  J Mol Evol       Date:  2003-11       Impact factor: 2.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.